ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0492

Outcomes of Total Knee Replacement in Patients with Rheumatoid Arthritis: A National Inpatient Sample Database Analysis

karun Shrestha1, Pravakar Parajuli2, Anil Regmi3, Prakriti Subedi4, Manoj Ghimire5, Sajana Poudel6, Mohammed Hasan7, Mahmoud Hashim8, Veera Durga Vaishnavi Kurra9 and ClementT Taoge10, 1Department of Internal Medicine, St. Barnabas Hospital, SBH Health System, Bronx, NY 10457, USA, BRONX, NY, 2Patan Academy of Health Sciences-School of Medicine (PAHS-SOM), Lalitpur, Bagmati, Nepal, 3Parkview Health, Fort Wayne, IN, 4St. Barnabas Hospital, Bronx, NY, 5St Barnabas Hospital, BRONX, NY, 6Cook County Health, CHICAGO, NY, 7Parkview Medical Center, Pueblo, CO, 8SBH Health System, New Rochelle, NY, 9University of Oklahoma Health Sciences Center, Oklahoma City, OK, 10Albert Einstein College of Medicine - Montefiore Medical Center, Bronx

Meeting: ACR Convergence 2025

Keywords: pain, rheumatoid arthritis, surgery, Total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0470–0505) Rheumatoid Arthritis – Treatment Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic, inflammatory disease of the joints with an estimated prevalence of 0.5% of people. Nearly 25% of RA patients undergo joint replacement/arthroplasty within 22 years of diagnosis. The hip and knee are the most frequently replaced joints. Total knee replacement (TKR) effectively treats advanced joint destruction in RA patients, significantly enhancing mobility and quality of life. Other common TKR indications include symptomatic moderate-to-severe osteoarthritis, advanced symptomatic osteonecrosis with arthritis, and limb deformity correction. Studies on outcomes of TKR in RA patients are limited. This study uses the national inpatient sample (NIS) database to compare characteristics, comorbidities, perioperative complications, and outcomes in TKR patients with and without RA.

Methods: A retrospective cross-sectional study was conducted using data from NIS (2016-2021). Primary and secondary diagnoses were identified using International Classification of Diseases (ICD-10) codes. All patients aged >18 years undergoing TKR were included in the study. TKR patients with and without RA were compared for demographics, comorbidities, complications, and outcomes, including mortality, length of stay, and hospitalization charges. Statistical analysis was done using STATA v.17.

Results: A total of 3,415,690 patients underwent TKR during the study period. Patients with RA undergoing TKR (n=127080) were more likely to be female (76.0% vs 60.6%, p< 0.001) and non-White. The most common sites were urban teaching hospitals. RA patients had significantly higher prevalence of comorbidities; congestive heart failure (5.2% vs 4.0%), COPD (22.3% vs 15.7%), and renal disease (8.7% vs 7.6%) - and significantly more complications including blood loss anemia (19.0% vs 15.0%, p< 0.001), blood transfusions (3.0% vs 1.6%), peri-prosthetic infection (2.9% vs 1.5%), dislocation (1.26% vs 0.89%), fracture (0.81% vs 0.38%), and superficial surgical site infection (0.03% vs 0.01%). RA patients had higher postoperative mortality (0.08% vs 0.04%, p=0.003), longer hospital stay (2.54 vs 2.31 days, p=0.01), and higher hospital charges ($72,002 vs $67,185, p< 0.001).

Conclusion: This study found that RA patients undergoing TKR experience higher perioperative complications, prolonged hospitalization, and higher costs. The study also demonstrated that patients with RA undergoing TKR had more comorbidities, with no significant age difference between those with and without RA. These findings underscore the importance of preoperative optimization and vigilant postoperative care in this vulnerable population. More studies are required to accurately identify the outcomes and complications of the TNR in RA patients.

Supporting image 1Table 1: Patient characteristics and co-morbidities

Supporting image 2Table 2: Comparisons of complications between two groups

Supporting image 3Table 3: Primary outcomes


Disclosures: k. Shrestha: None; P. Parajuli: None; A. Regmi: None; P. Subedi: None; M. Ghimire: None; S. Poudel: None; M. Hasan: None; M. Hashim: None; V. Kurra: None; C. Taoge: None.

To cite this abstract in AMA style:

Shrestha k, Parajuli P, Regmi A, Subedi P, Ghimire M, Poudel S, Hasan M, Hashim M, Kurra V, Taoge C. Outcomes of Total Knee Replacement in Patients with Rheumatoid Arthritis: A National Inpatient Sample Database Analysis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/outcomes-of-total-knee-replacement-in-patients-with-rheumatoid-arthritis-a-national-inpatient-sample-database-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/outcomes-of-total-knee-replacement-in-patients-with-rheumatoid-arthritis-a-national-inpatient-sample-database-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology